Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCR: Oral Cyclophosphamide and Sirolimus in Advanced Sarcoma
NCT00743509Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Aug 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in osteosarcoma (OS), Ewing sarcoma, soft tissue sarcoma (STS), sponsored by University of Michigan Rogel Cancer Center. Started Aug 2008; status: completed.
02
Drugs
sirolimus
03
Conditions
osteosarcoma (OS)Ewing sarcomasoft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00743509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00743509.